Wed, November 20, 2019
Tue, November 19, 2019
Mon, November 18, 2019

Elemer Piros Maintained (ARWR) at Hold with Increased Target to $50 on, Nov 19th, 2019

Elemer Piros of Cantor Fitzgerald, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold with Increased Target from $24 to $50 on, Nov 19th, 2019.

Elemer has made no other calls on ARWR in the last 4 months.



There are 3 other peers that have a rating on ARWR. Out of the 3 peers that are also analyzing ARWR, 1 agrees with Elemer's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joel Beatty of "Baird" Downgraded from Buy to Hold and Held Target at $39 on, Thursday, October 24th, 2019


These are the ratings of the 2 analyists that currently disagree with Elemer


  • Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $59 on, Wednesday, November 13th, 2019
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $45 on, Tuesday, October 22nd, 2019